CN Patent

CN105263476A — 用于治疗炎症的免疫修饰性颗粒

Assigned to Cour Pharmaceuticals Development Co Inc · Expires 2016-01-20 · 10y expired

What this patent protects

本发明涉及给受试者施用带负电的颗粒诸如聚苯乙烯、PLGA或金刚石颗粒以改善炎性免疫反应。另外，本发明描述了通过施用这些相同的带负电的颗粒来治疗炎性疾病的方法。

USPTO Abstract

本发明涉及给受试者施用带负电的颗粒诸如聚苯乙烯、PLGA或金刚石颗粒以改善炎性免疫反应。另外，本发明描述了通过施用这些相同的带负电的颗粒来治疗炎性疾病的方法。

Drugs covered by this patent

Travatan (TRAVOPROST)

Patent Metadata

Patent number: CN105263476A
Jurisdiction: CN
Classification: —
Expires: 2016-01-20
Drug substance claim: No
Drug product claim: No
Assignee: Cour Pharmaceuticals Development Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.